Antipsychotic medication usage is linked to brain injuries in individuals with Alzheimer's disease, according to a new study.
Antipsychotic medication usage is linked to an increased risk of head injuries in patients with Alzheimer's disease, according to a study published in the Journal of the American Geriatrics Society. The nationwide study of individuals in Finland who were diagnosed with Alzheimer's disease from 2005 to 2011 included 21,795 patients who started taking antipsychotic medications and 21,795 patients who did not.
‘Patients with Alzheimer's who have a higher risk of falling, head injuries, and traumatic brain injuries should be careful while using antipsychotic medications.’
Read More..
Use of anti psychotic medications was linked with a 29% higher risk of head injuries--the "event rate" was 1.65 vs. 1.26 per 100 person-years in users vs. non-users. (This means there would be an average of 1.65 vs. 1.26 injuries among 100 people over one year. This translates to 165 vs. 126 injuries per 10,000 people.) Also, use of anti psychotic medications was linked with a 22% higher risk of traumatic brain injuries--0.90 vs. 0.72 per 100 person-years. Read More..
When comparing antipsychotic medications, quetiapine users had 60% higher risk of traumatic brain injuries compared with risperidone users.
"Persons with Alzheimer's disease have a higher risk of falling, head injuries, and traumatic brain injuries and worse prognosis after these events in comparison to those without Alzheimer's disease.Therefore, it is important to avoid further increasing risk with antipsychotics in this vulnerable population, if possible," said lead author Vesa Tapiainen, MD, of the University of Eastern Finland.
Source-Eurekalert